|
|
|
Volumn 5, Issue 1, 1999, Pages 3-5
|
|
Topotecan: What dose, what schedule, what route?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IRINOTECAN;
TOPOTECAN;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DIARRHEA;
EDITORIAL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
OVARY CANCER;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION ROUTES;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
TOPOTECAN;
|
|
EID: 0032899370
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (20)
|
|
References (21)
|
